Recent Quarter Total Invested
$213,171
-$201,829.00
Recent Quarter Institutional Ownership Percentage
4.22%
-$1.10
Total Invested of Last Quarter
$415,000
Ownership Percentage of Last Quarter
5.32%
Phio Pharmaceuticals Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 166,800 | $62,000 | -21.91% | 1.22% |
| VANGUARD GROUP INC | 02/10/2023 | 154,536 | $57,487 | -29.17% | 1.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 106,917 | $39,000 | -0.26% | 0.78% |
| CETERA INVESTMENT ADVISERS | 02/14/2023 | 75,000 | $27,900 | 0.00% | 0.55% |
| UBS GROUP AG | 02/08/2023 | 23,029 | $8,521 | 100.00% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2023 | 22,398 | $8,332 | -3.45% | 0.16% |
| TWO SIGMA SECURITIES, LLC | 02/14/2023 | 19,707 | $7,331 | -11.69% | 0.14% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 5,220 | $2,000 | -4.48% | 0.04% |
| MORGAN STANLEY | 02/14/2023 | 1,500 | $558 | -0.13% | 0.01% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 93 | $35 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/13/2023 | 50 | $0 | -94.25% | 0.00% |
| BLACKROCK INC. | 02/13/2023 | 19 | $7 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 01/30/2023 | 0 | $0 | 0.00% | 0.00% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| ERGOTELES LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
Phio Pharmaceuticals Corp.institutional Ownership - Frequently Asked Questions
-
What percentage of Phio Pharmaceuticals Corp. stock is owned by institutional investors?
4.22% of Phio Pharmaceuticals Corp. stock is owned by institutional investors.